FindTrial
Sign In

Pharmacist Interventions for Antibiotic Use: A Cost-effectiveness Analysis

Pharmacist Interventions for Antibiotic Use: A Cost-effectiveness Analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008057
Enrollment
Unknown
Registered
2016-03-06
Start date
2016-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Intervention group:Pharmacist service
Control group:Non-pharmacist service

Sponsors

West China Second University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Aged 0-18 years old pediatric sepsis patients in ICU ward; 2. Intervention: pharmacist service; 3. Comparison: non-pharmacist service; 4. Outcomes:cost including direct medical and pharmacist cost;effectiveness including antibiotic use density, antibiotic medical error rate,quality of life,adverse drug event rate.

Exclusion criteria

Exclusion criteria: Patient's guardian refused to attend the study or language barrier reesulting in unable to communicate; Patients in palliative care

Design outcomes

Primary

MeasureTime frame
Cost;antibiotic use density;antibiotic medical error rate;—

Secondary

MeasureTime frame
quality of life;adverse drug event rate;—

Countries

China

Contacts

Public ContactZhang Lingli

West China Second University Hospital

zhlingli@sina.com+86 028-85503205

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026